Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-Reported Outcome Questionnaire Development for Symptoms of Systemic Mastocytosis

NCT02380222 is registered in ClinicalTrials.gov with Adelphi Values LLC as lead sponsor.

NCT NCT02380222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02380222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-Reported Outcome Questionnaire Development for Symptoms of Systemic Mastocytosis
Lead sponsor
Adelphi Values LLC
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
December 31, 2015
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aggressive systemic mastocytosis (asm), indolent systemic mastocytosis (ism) ism subgroup fully recruited, mast cell leukemia (mcl), sm w assoc clonal hema non-mast cell lineage disease (sm-ahnmd), smoldering systemic mastocytosis (ssm)